Unrecognized glucose intolerance is common in pulmonary arterial hypertension

Journal of Heart and Lung Transplantation

Volumn 30, Issue 8, 2011, Pages 904-911

  Pugh, Meredith E ^a   Robbins, Ivan M ^a   Rice, Todd W ^a   West, James ^a   Newman, John H ^a   Hemnes, Anna R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

glucose intolerance; hemoglobin A1c; insulin resistance; pulmonary arterial hypertension; pulmonary hypertension

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE INTOLERANCE; HEMODYNAMICS; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADULT; AGED; BLOOD PRESSURE; COMORBIDITY; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION, PULMONARY; INSULIN RESISTANCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 79960013903     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.02.016     Document Type: Article

References (42)

1. R.M. Tuder, S.H. Abman, and T. Braun Development and pathology of pulmonary hypertension J Am Coll Cardiol 54 suppl 1 2009 S3 S9
2. R. Summer, C.A. Fiack, and Y. Ikeda Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease Am J Physiol Lung Cell Mol Physiol 297 2009 L432 L438
3. I.M. Robbins, J.H. Newman, and R.F. Johnson Association of the metabolic syndrome with pulmonary venous hypertension Chest 136 2009 31 36
4. R.T. Zamanian, G. Hansmann, and S. Snook Insulin resistance in pulmonary arterial hypertension Eur Respir J 33 2009 318 324
5. S. Ameshima, H. Golpon, and C.D. Cool Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth Circ Res 92 2003 1162 1169 (Pubitemid 36665863)
6. G. Hansmann, and M. Rabinovitch The protective role of adiponectin in pulmonary vascular disease Am J Physiol Lung Cell Mol Physiol 298 2010 L1 L2
7. G. Hansmann, R.A. Wagner, and S. Schellong Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation Circulation 115 2007 1275 1284 (Pubitemid 46594772)
8. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83 (Pubitemid 29299050)
9. C. Heidemann, Q. Sun, R.M. van Dam, and J.B. Meigs Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women Ann Intern Med 149 2008 307 316
10. J. Spranger, A. Kroke, and M. Mohlig Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226 228 (Pubitemid 36126226)
11. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 suppl 1 2010 S62 S69
12. C.C. Cowie, K.F. Rust, and D.D. Byrd-Holt Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 19882006 Diabetes Care 33 2010 562 568
13. D.B. Badesch, H.C. Champion, and M.A. Sanchez Diagnosis and assessment of pulmonary arterial hypertension J Am Coll Cardiol 54 suppl 1 2009 S55 S66
14. ATS statement: guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
15. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
16. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes Endocr Pract 16 2010 155 156
17. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndromea new world-wide definition A Consensus Statement from the International Diabetes Federation Diabet Med 23 2006 469 480
18. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Arterioscler Thromb Vasc Biol 24 2004 e13 e18
19. K.G. Alberti, R.H. Eckel, and S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
20. T. Shimazaki, T. Kadowaki, Y. Ohyama, K. Ohe, and K. Kubota Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital Transl Res 149 2007 196 204 (Pubitemid 46442008)
21. A.D. Pradhan, N. Rifai, J.E. Buring, and P.M. Ridker Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women Am J Med 120 2007 720 727 (Pubitemid 47176521)
22. D. Edelman, M.K. Olsen, T.K. Dudley, A.C. Harris, and E.Z. Oddone Utility of hemoglobin A1c in predicting diabetes risk J Gen Intern Med 19 2004 1175 1180 (Pubitemid 40041381)
23. E. Selvin, M.W. Steffes, and H. Zhu Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
24. Y.J. Cheng, H.S. Kahn, E.W. Gregg, G. Imperatore, and L.S. Geiss Recent population changes in HbA(1c) and fasting insulin concentrations among US adults with preserved glucose homeostasis Diabetologia 53 2010 1890 1893
25. P.M. Hassoun, L. Mouthon, and J.A. Barbera Inflammation, growth factors, and pulmonary vascular remodeling J Am Coll Cardiol 54 suppl 1 2009 S10 S19
26. M. Humbert, G. Monti, and F. Brenot Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension Am J Respir Crit Care Med 151 1995 1628 1631
27. M.A. Mamas, C. Deaton, and M.K. Rutter Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? J Card Fail 16 2010 761 768
28. M. Kim, J.K. Oh, and S. Sakata Role of resistin in cardiac contractility and hypertrophy J Mol Cell Cardiol 45 2008 270 280
29. E.J. Mayer-Davis, R. D'Agostino Jr, and A.J. Karter Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study JAMA 279 1998 669 674 (Pubitemid 28138735)
30. J.A. Houmard, C.J. Tanner, C.A. Slentz, B.D. Duscha, J.S. McCartney, and W.E. Kraus Effect of the volume and intensity of exercise training on insulin sensitivity J Appl Physiol 96 2004 101 106 (Pubitemid 38031988)
31. E. Ingelsson, J. Sundstrom, J. Arnlov, B. Zethelius, and L. Lind Insulin resistance and risk of congestive heart failure JAMA 294 2005 334 341 (Pubitemid 41043777)
32. G.A. Nichols, B. Arondekar, and W.H. Herman Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia Am J Manag Care 14 2008 791 798
33. R.M. Witteles, and M.B. Fowler Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options J Am Coll Cardiol 51 2008 93 102
34. P. Van De Borne, M. Hausberg, R.P. Hoffman, A.L. Mark, and E.A. Anderson Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects Am J Physiol 276 1999 R178 R183
35. T.B. Horwich, and G.C. Fonarow Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure J Am Coll Cardiol 55 2010 283 293
36. W. Doehner, M. Rauchhaus, and P. Ponikowski Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure J Am Coll Cardiol 46 2005 1019 1026 (Pubitemid 41316509)
37. H.C. Gerstein, K. Swedberg, and J. Carlsson The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Arch Intern Med 168 2008 1699 1704
38. M. Humbert, O. Sitbon, and A. Chaouat Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163
39. D.E. Laaksonen, H.M. Lakka, J.T. Salonen, L.K. Niskanen, R. Rauramaa, and T.A. Lakka Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome Diabetes Care 25 2002 1612 1618 (Pubitemid 41071120)
40. D. Mereles, N. Ehlken, and S. Kreuscher Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension Circulation 114 2006 1482 1489 (Pubitemid 44527003)
41. N.J. Snowling, and W.G. Hopkins Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis Diabetes Care 29 2006 2518 2527 (Pubitemid 44912265)
42. D.B. Badesch, G.E. Raskob, and C.G. Elliott Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry Chest 137 2010 376 387